We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAXX
3051
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$17K ﹤0.01%
+12,000
New +$20.2K
SOLO
3052
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$17K ﹤0.01%
28,349
-1,107
-4% -$1.18K
VCSA
3053
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$17K ﹤0.01%
665
-76
-10% -$3.54K
NAK
3054
Northern Dynasty Minerals
NAK
$953M
$16K ﹤0.01%
72,160
-2,000
-3% -$483
ZTEK
3055
Zentek
ZTEK
$79.7M
$16K ﹤0.01%
10,500
SHCR
3056
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$16K ﹤0.01%
10,200
-20
-0.2% -$37
DXYN
3057
DELISTED
Dixie Group Inc
DXYN
$16K ﹤0.01%
+20,000
New +$19.8K
SCPX
3058
DELISTED
Scorpius Holdings, Inc.
SCPX
$16K ﹤0.01%
5
-1
-17% -$5.49K
BGRY
3059
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$16K ﹤0.01%
26,818
+2,580
+11% +$2.88K
CIFR icon
3060
Cipher Digital
CIFR
$7.42B
$15K ﹤0.01%
26,750
MVST icon
3061
Microvast
MVST
$354M
$15K ﹤0.01%
10,010
ISUN
3062
DELISTED
iSun, Inc. Common Stock
ISUN
$15K ﹤0.01%
11,202
AIM
3063
AIM ImmunoTech
AIM
$7.13M
$15K ﹤0.01%
467
-5
-1% -$232
GLMD icon
3064
Galmed Pharmaceuticals
GLMD
$4.63M
$14K ﹤0.01%
158
-37
-19% -$2.42K
CCLP
3065
DELISTED
CSI Compressco LP
CCLP
$14K ﹤0.01%
+10,441
New +$13.4K
VHC icon
3066
VirnetX Holding Corp
VHC
$65.8M
$13K ﹤0.01%
516
-75
-13% -$1.86K
LMDX
3067
DELISTED
LumiraDx Limited Common Shares
LMDX
$13K ﹤0.01%
14,902
DMK
3068
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$12K ﹤0.01%
1,000
+81
+9% +$926
TTCF
3069
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$12K ﹤0.01%
10,094
-15,202
-60% -$45.1K
CHGA
3070
Change Agents Corporation Common Stock
CHGA
$3.02M
$11K ﹤0.01%
+140
New +$9.55K
HUT
3071
Hut 8
HUT
$11.2B
$11K ﹤0.01%
2,705
-7,507
-74% -$56.6K
AXDX
3072
DELISTED
Accelerate Diagnostics
AXDX
$10K ﹤0.01%
1,452
FIRY
3073
Firy Inc
FIRY
$156M
$10K ﹤0.01%
948
-575
-38% -$10.6K
VRPX
3074
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$10K ﹤0.01%
66
-1
-1% -$228
USAS
3075
Americas Gold and Silver
USAS
$1.75B
$8K ﹤0.01%
5,326
-5,538
-51% -$7.08K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.